Paper7708765
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
Zhou X and 4 others. Proc Natl Acad Sci U S A, 1995. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus. Papers, record 7708765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7708765
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD8-Positive T-Lymphocytes | Major topic |
| Influenza A virus | Major topic |
| Semliki forest virus | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antibody Formation | |
| Cytotoxicity, Immunologic | |
| H-2 Antigens | |
| Immunologic Memory | |
| Melanoma, Experimental | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Molecular Sequence Data | |
| Oligopeptides | |
| Recombination, Genetic | |
| Thymoma | |
| Thymus Neoplasms | |
| Tumor Cells, Cultured | |
| Vaccines, Synthetic | |
| Viral Vaccines | |
| Virus Replication |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1692084 | Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. | J Exp Med | 1990 | https://conductscience.org/library/papers/1692084 | PubMed |
| 2 | 6160740 | The virology and immunobiology of lymphocytic choriomeningitis virus infection. | Adv Immunol | 1980 | https://conductscience.org/library/papers/6160740 | PubMed |
| 3 | 1700304 | Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. | Nature | 1990 | https://conductscience.org/library/papers/1700304 | PubMed |
| 4 | 2258191 | Follicular dendritic cells as accessory cells. | Immunol Rev | 1990 | https://conductscience.org/library/papers/2258191 | PubMed |
| 5 | 1992491 | Peptide-induced antiviral protection by cytotoxic T cells. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1992491 | PubMed |
| 6 | 1848698 | Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1848698 | PubMed |
| 7 | 1673361 | CD8 is needed for development of cytotoxic T cells but not helper T cells. | Cell | 1991 | https://conductscience.org/library/papers/1673361 | PubMed |
| 8 | 2072444 | Recombination between Sindbis virus RNAs. | J Virol | 1991 | https://conductscience.org/library/papers/2072444 | PubMed |
| 9 | 1832488 | Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. | Nature | 1991 | https://conductscience.org/library/papers/1832488 | PubMed |
| 10 | 1936113 | Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells. | Eur J Immunol | 1991 | https://conductscience.org/library/papers/1936113 | PubMed |
| 11 | 1682377 | Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides. | J Immunol | 1991 | https://conductscience.org/library/papers/1682377 | PubMed |
| 12 | 1683893 | Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. | J Exp Med | 1991 | https://conductscience.org/library/papers/1683893 | PubMed |
| 13 | 1757108 | In vivo efficacy of virus-derived peptides and virus-specific cytotoxic T lymphocytes. | Immunol Lett | 1991 | https://conductscience.org/library/papers/1757108 | PubMed |
| 14 | 1370252 | A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. | Biotechnology (N Y) | 1991 | https://conductscience.org/library/papers/1370252 | PubMed |
| 15 | 1370348 | Infectious enveloped RNA virus antigenic chimeras. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1370348 | PubMed |
| 16 | 1730759 | Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry. | J Cell Biol | 1992 | https://conductscience.org/library/papers/1730759 | PubMed |
| 17 | 1545867 | Genetic immunization is a simple method for eliciting an immune response. | Nature | 1992 | https://conductscience.org/library/papers/1545867 | PubMed |
| 18 | 1372256 | Gene transfer experiments imply instructive role of major histocompatibility complex class I molecules in cellular peptide processing. | Eur J Immunol | 1992 | https://conductscience.org/library/papers/1372256 | PubMed |
| 19 | 1312473 | Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice. | Eur J Immunol | 1992 | https://conductscience.org/library/papers/1312473 | PubMed |
| 20 | 1372987 | Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1372987 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36678486 | Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development. | Pathogens | 2023 | https://conductscience.org/library/papers/36678486 | PubMed |
| 35322018 | Advances in COVID-19 mRNA vaccine development. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35322018 | PubMed |
| 34531860 | Influenza Viruses: Innate Immunity and mRNA Vaccines. | Front Immunol | 2021 | https://conductscience.org/library/papers/34531860 | PubMed |
| 33571426 | Synthetic biology in the clinic: engineering vaccines, diagnostics, and therapeutics. | Cell | 2021 | https://conductscience.org/library/papers/33571426 | PubMed |
| 33202961 | Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/33202961 | PubMed |
| 26347489 | Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice. | BMC Cancer | 2015 | https://conductscience.org/library/papers/26347489 | PubMed |
| 24795357 | Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates. | Cancer Immunol Res | 2014 | https://conductscience.org/library/papers/24795357 | PubMed |
| 23785460 | The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon. | PLoS One | 2013 | https://conductscience.org/library/papers/23785460 | PubMed |
| 21994644 | RNA replicons - a new approach for influenza virus immunoprophylaxis. | Viruses | 2010 | https://conductscience.org/library/papers/21994644 | PubMed |
| 21261958 | Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines. | Virol J | 2011 | https://conductscience.org/library/papers/21261958 | PubMed |
| 20844763 | Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. | PLoS One | 2010 | https://conductscience.org/library/papers/20844763 | PubMed |
| 19002981 | Large scale transient 5-HT3 receptor production with the Semliki Forest Virus Expression System. | Cytotechnology | 2000 | https://conductscience.org/library/papers/19002981 | PubMed |
| 18004406 | Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition. | Gene Ther | 2008 | https://conductscience.org/library/papers/18004406 | PubMed |
| 17459927 | Viral alteration of cellular translational machinery increases defective ribosomal products. | J Virol | 2007 | https://conductscience.org/library/papers/17459927 | PubMed |
| 15908354 | An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice. | Infect Immun | 2005 | https://conductscience.org/library/papers/15908354 | PubMed |
| 15750833 | Induction of specific human primary immune responses to a Semliki Forest virus-based tumor vaccine in a Trimera mouse model. | Cancer Immunol Immunother | 2005 | https://conductscience.org/library/papers/15750833 | PubMed |
| 11857066 | Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. | Gene Ther | 2002 | https://conductscience.org/library/papers/11857066 | PubMed |
| 11704811 | Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines. | Gene Ther | 2001 | https://conductscience.org/library/papers/11704811 | PubMed |
| 11571567 | Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response. | Gene Ther | 2001 | https://conductscience.org/library/papers/11571567 | PubMed |
| 11313804 | Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF. | Gene Ther | 2001 | https://conductscience.org/library/papers/11313804 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7708765
GET https://conductscience.org/api/papers/v1/7708765/references?page=2